Key result
Stroke mechanisms, revised definitions, and the use of antiplatelet and anticoagulant drugs for carotid and cardiac disease are reviewed for patients with chronic kidney disease.
This review summarizes stroke mechanisms, definitions, and the use of antiplatelet and anticoagulant drugs for stroke prevention in chronic kidney disease.
Answers are grounded in this paper and cite their sources.
May inform antithrombotic decisions in CKD stroke prevention; leaves optimal regimens open for dedicated trials.
This is a review of stroke mechanisms and management. The concept of stroke and transient ischemic attack and the recently proposed revision in definitions and controversies are discussed. We also discuss the use of antiplatelet and anticoagulant drugs for stroke due to carotid and cardiac disease.
No takes yet. Share an insight, caveat, or question.
Khella et al. (2007) studied this question. Stroke mechanisms, revised definitions, and the use of antiplatelet and anticoagulant drugs for carotid and cardiac disease are reviewed for patients with chronic kidney disease.
Synapse has enriched 10 related papers. Consider them for comparative context: